KERRI WINGARD: Open Payments
NPI 1174274351 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,604 in 158 payments from 21 companies in 2025. Trend: 2023 $3,060 · 2024 $2,644 · 2025 $2,604
Food & beverage: $2,419Education: $185
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 30 | $617 |
| GlaxoSmithKline, LLC. | 58 | $614 |
| GENZYME CORPORATION | 7 | $301 |
| Verona Pharma, Inc. | 6 | $178 |
| Regeneron Healthcare Solutions, Inc. | 11 | $150 |
| Actelion Pharmaceuticals US, Inc. | 3 | $137 |
| Grifols USA, LLC | 4 | $87 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| Viatris Specialty LLC | 4 | $63 |
| Insmed, Inc. | 3 | $57 |
Products named: DUPIXENT, NUCALA, TRELEGY ELLIPTA, Ohtuvayre, AIRSUPRA, BREZTRI, TEZSPIRE, OPSUMIT.
Industry payments across PA — which companies pay providers there.
